118 related articles for article (PubMed ID: 21910584)
1. PIM1-activated PRAS40 regulates radioresistance in non-small cell lung cancer cells through interplay with FOXO3a, 14-3-3 and protein phosphatases.
Kim W; Youn H; Seong KM; Yang HJ; Yun YJ; Kwon T; Kim YH; Lee JY; Jin YW; Youn B
Radiat Res; 2011 Nov; 176(5):539-52. PubMed ID: 21910584
[TBL] [Abstract][Full Text] [Related]
2. PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells.
Kim W; Youn H; Kwon T; Kang J; Kim E; Son B; Yang HJ; Jung Y; Youn B
Pharmacol Res; 2013 Apr; 70(1):90-101. PubMed ID: 23352980
[TBL] [Abstract][Full Text] [Related]
3. Intracellular calcium promotes radioresistance of non-small cell lung cancer A549 cells through activating Akt signaling.
Wang Y; He J; Zhang S; Yang Q
Tumour Biol; 2017 Mar; 39(3):1010428317695970. PubMed ID: 28351325
[TBL] [Abstract][Full Text] [Related]
4. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells.
Zhang F; Beharry ZM; Harris TE; Lilly MB; Smith CD; Mahajan S; Kraft AS
Cancer Biol Ther; 2009 May; 8(9):846-53. PubMed ID: 19276681
[TBL] [Abstract][Full Text] [Related]
5. CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells.
Li H; Che J; Jiang M; Cui M; Feng G; Dong J; Zhang S; Lu L; Liu W; Fan S
Cell Commun Signal; 2020 Sep; 18(1):152. PubMed ID: 32943060
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of ribosomal protein S3 and antiapoptotic TRAF2 protein mediates radioresistance in non-small cell lung cancer cells.
Yang HJ; Youn H; Seong KM; Jin YW; Kim J; Youn B
J Biol Chem; 2013 Feb; 288(5):2965-75. PubMed ID: 23188828
[TBL] [Abstract][Full Text] [Related]
7. PTEN/pAkt/p53 signaling pathway correlates with the radioresponse of non-small cell lung cancer.
Jung IL; Kang HJ; Kim KC; Kim IG
Int J Mol Med; 2010 Apr; 25(4):517-23. PubMed ID: 20198299
[TBL] [Abstract][Full Text] [Related]
8. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
Cao L; Wang F; Li S; Wang X; Huang D; Jiang R
Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073
[TBL] [Abstract][Full Text] [Related]
9. A novel role for NFIA in restoring radiosensitivity in radioresistant NSCLC cells by downregulating the AKT and ERK pathways.
Sun C; Li Y; Tan Y; Zhang H; Liang Y; Zeng J; Yu J; Zou H
Biochem Biophys Res Commun; 2019 Aug; 515(4):558-564. PubMed ID: 31178144
[TBL] [Abstract][Full Text] [Related]
10. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
[TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT.
Singh A; Ye M; Bucur O; Zhu S; Tanya Santos M; Rabinovitz I; Wei W; Gao D; Hahn WC; Khosravi-Far R
Mol Biol Cell; 2010 Mar; 21(6):1140-52. PubMed ID: 20110348
[TBL] [Abstract][Full Text] [Related]
12. Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis.
Huang B; Porter G
Acta Pharmacol Sin; 2005 Oct; 26(10):1253-8. PubMed ID: 16174443
[TBL] [Abstract][Full Text] [Related]
13. Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells.
Zheng F; Wu J; Zhao S; Luo Q; Tang Q; Yang L; Li L; Wu W; Hann SS
J Exp Clin Cancer Res; 2015 May; 34(1):41. PubMed ID: 25948105
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells.
Kang J; Kim W; Kwon T; Youn H; Kim JS; Youn B
Oncotarget; 2016 Apr; 7(17):23961-74. PubMed ID: 27004408
[TBL] [Abstract][Full Text] [Related]
15. PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma.
Park M; Yoon HJ; Kang MC; Kwon J; Lee HW
Tumour Biol; 2016 Oct; 37(10):14217-14224. PubMed ID: 27557627
[TBL] [Abstract][Full Text] [Related]
16. Gelsolin Promotes Radioresistance in Non-Small Cell Lung Cancer Cells Through Activation of Phosphoinositide 3-Kinase/Akt Signaling.
Zhao RS; Wang W; Li JP; Liu CM; He L
Technol Cancer Res Treat; 2017 Aug; 16(4):512-518. PubMed ID: 27121073
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy diagnostic biomarkers in radioresistant human H460 lung cancer stem-like cells.
Yun HS; Baek JH; Yim JH; Um HD; Park JK; Song JY; Park IC; Kim JS; Lee SJ; Lee CW; Hwang SG
Cancer Biol Ther; 2016; 17(2):208-18. PubMed ID: 26901847
[TBL] [Abstract][Full Text] [Related]
18. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
Yao YH; Cui Y; Qiu XN; Zhang LZ; Zhang W; Li H; Yu JM
Chin J Cancer; 2016 Jun; 35():50. PubMed ID: 27266881
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-induced radioresistance is mediated by ROS-dependent inactivation of protein phosphatase 1 in non-small cell lung cancer cells.
Kim W; Youn H; Kang C; Youn B
Apoptosis; 2015 Sep; 20(9):1242-52. PubMed ID: 26033480
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation.
Hsieh FS; Hung MH; Wang CY; Chen YL; Hsiao YJ; Tsai MH; Li JR; Chen LJ; Shih CT; Chao TI; Chen KF
Lung Cancer; 2017 Oct; 112():81-89. PubMed ID: 29191605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
